<database>
  <name>MetabolomicsWorkbench</name>
  <description>The Metabolomics Workbench will serve as a national and international repository for metabolomics data and metadata and will provide analysis tools and access to metabolite standards, protocols, tutorials, training, and more.</description>
  <release>1.0</release>
  <release_date>15-05-20</release_date>
  <entry_count>1</entry_count>
  <entries>
    <entry id="ST000053">
      <name>Metabolic Microenvironments in Normal Breast and Breast Cancer (NMR analysis)</name>
      <description>The purpose of this study was to understand the genomic and metabolomic changes in the breast tissue microenvironment at various stages of cancer development and progression (i.e. normal breast, DCIS, benign disease and invasive cancer). To understand the way in which metabolic microenvironments evolve with breast cancer, this study analyzed normal breast tissue adjacent to benign and malignant lesions at various stages of cancer development and studied samples adjacent to invasive cancers of distinct breast cancer subtypes.</description>
      <cross_references>
        <ref dbkey="9606" dbname="TAXONOMY"/>
      </cross_references>
      <dates>
        <date type="submission" value="14-04-15"/>
      </dates>
      <additional_fields>
        <field name="omics_type">Metabolomics</field>
        <field name="full_dataset_link">http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&amp;StudyID=ST000053</field>
        <field name="repository">MetabolomicsWorkbench</field>
        <field name="data_protocol">1H NMR 700 MHz</field>
        <field name="instrument_platform">Bruker Avance III</field>
        <field name="study_factor">Treatment Group :HER2 IDC </field>
        <field name="study_factor">Treatment Group :Reduction </field>
        <field name="study_factor">Treatment Group :Luminal-A IDC </field>
        <field name="study_factor">Treatment Group :Pool_DCIS </field>
        <field name="study_factor">Treatment Group :Pool_HER2 </field>
        <field name="study_factor">Treatment Group :Pool_All </field>
        <field name="study_factor">Treatment Group :Basal-like IDC </field>
        <field name="study_factor">Treatment Group :Pool_Basal </field>
        <field name="study_factor">Treatment Group :Pool_LumB </field>
        <field name="study_factor">Treatment Group :DCIS </field>
        <field name="study_factor">Treatment Group :Pool_LumA </field>
        <field name="study_factor">Treatment Group :Luminal-B IDC </field>
        <field name="study_factor">Treatment Group :Pool_Reduc </field>
        <field name="species">Homo sapiens</field>
        <field name="technology_type">Bruker Avance III</field>
        <field name="submitter">Susan Sumner</field>
        <field name="submitter_mail">ssumner@rti.org</field>
        <field name="submitter_affiliation">Systems and Translational Sciences, RTI International</field>
      </additional_fields>
    </entry>
  </entries>
</database>
